RxERP Releases Major Upgrade to Serialized ERP Solution

The Hub upgrade aims to streamline operations for pharmaceutical and medical device companies.

Apr. 8, 2026 at 7:27pm

A photorealistic studio still life featuring a collection of polished, geometric pharmaceutical and medical device components arranged elegantly on a clean, monochromatic background, conceptually representing the abstract challenges of supply chain management and regulatory compliance in the medical industry.A high-end studio still life captures the precision and complexity of the medical supply chain.Salt Lake City Today

RxERP, a leading provider of enterprise resource planning (ERP) software for the pharmaceutical and medical device industries, has announced the release of a major upgrade to its industry-leading serialized ERP solution. Called 'The Hub', the new upgrade is designed to streamline operations and improve efficiency for companies in these highly regulated sectors.

Why it matters

The pharmaceutical and medical device industries face unique challenges around supply chain management, regulatory compliance, and serialization requirements. RxERP's serialized ERP solution helps companies in these sectors address these complexities, and the new Hub upgrade aims to further enhance their capabilities.

The details

The Hub upgrade includes several new features and enhancements, such as improved lot and serial number tracking, enhanced reporting and analytics, and tighter integration with other enterprise systems. RxERP says the upgrade will help customers better manage their serialized inventory, improve visibility across their supply chain, and ensure regulatory compliance.

  • RxERP announced the release of The Hub upgrade on April 8, 2026.

The players

RxERP

A leading provider of enterprise resource planning (ERP) software for the pharmaceutical and medical device industries.

Got photos? Submit your photos here. ›

The takeaway

The Hub upgrade from RxERP demonstrates the company's commitment to providing innovative solutions that address the unique challenges faced by pharmaceutical and medical device companies. This upgrade is expected to help customers in these highly regulated industries streamline their operations and maintain compliance.